Cargando…

Atopic Dermatitis Studies through In Vitro Models

Atopic dermatitis (AD) is a complex inflammatory skin condition that is not fully understood. Epidermal barrier defects and Th2 immune response dysregulations are thought to play crucial roles in the pathogenesis of the disease. A vicious circle takes place between these alterations, and it can furt...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vuyst, Evelyne, Salmon, Michel, Evrard, Céline, Lambert de Rouvroit, Catherine, Poumay, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523664/
https://www.ncbi.nlm.nih.gov/pubmed/28791291
http://dx.doi.org/10.3389/fmed.2017.00119
_version_ 1783252357416484864
author De Vuyst, Evelyne
Salmon, Michel
Evrard, Céline
Lambert de Rouvroit, Catherine
Poumay, Yves
author_facet De Vuyst, Evelyne
Salmon, Michel
Evrard, Céline
Lambert de Rouvroit, Catherine
Poumay, Yves
author_sort De Vuyst, Evelyne
collection PubMed
description Atopic dermatitis (AD) is a complex inflammatory skin condition that is not fully understood. Epidermal barrier defects and Th2 immune response dysregulations are thought to play crucial roles in the pathogenesis of the disease. A vicious circle takes place between these alterations, and it can further be complicated by additional genetic and environmental factors. Studies investigating in more depth the etiology of the disease are thus needed in order to develop functional treatments. In recent years, there have been significant advances regarding in vitro models reproducing important features of AD. However, since a lot of models have been developed, finding the appropriate experimental setting can be difficult. Therefore, herein, we review the different types of in vitro models mimicking features of AD. The simplest models are two-dimensional culture systems composed of immune cells or keratinocytes, whereas three-dimensional skin or epidermal equivalents reconstitute more complex stratified tissues exhibiting barrier properties. In those models, hallmarks of AD are obtained, either by challenging tissues with interleukin cocktails overexpressed in AD epidermis or by silencing expression of pivotal genes encoding epidermal barrier proteins. Tissue equivalents cocultured with lymphocytes or containing AD patient cells are also described. Furthermore, each model is placed in its study context with a brief summary of the main results obtained. In conclusion, the described in vitro models are useful tools to better understand AD pathogenesis, but also to screen new compounds in the field of AD, which probably will open the way to new preventive or therapeutic strategies.
format Online
Article
Text
id pubmed-5523664
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-55236642017-08-08 Atopic Dermatitis Studies through In Vitro Models De Vuyst, Evelyne Salmon, Michel Evrard, Céline Lambert de Rouvroit, Catherine Poumay, Yves Front Med (Lausanne) Medicine Atopic dermatitis (AD) is a complex inflammatory skin condition that is not fully understood. Epidermal barrier defects and Th2 immune response dysregulations are thought to play crucial roles in the pathogenesis of the disease. A vicious circle takes place between these alterations, and it can further be complicated by additional genetic and environmental factors. Studies investigating in more depth the etiology of the disease are thus needed in order to develop functional treatments. In recent years, there have been significant advances regarding in vitro models reproducing important features of AD. However, since a lot of models have been developed, finding the appropriate experimental setting can be difficult. Therefore, herein, we review the different types of in vitro models mimicking features of AD. The simplest models are two-dimensional culture systems composed of immune cells or keratinocytes, whereas three-dimensional skin or epidermal equivalents reconstitute more complex stratified tissues exhibiting barrier properties. In those models, hallmarks of AD are obtained, either by challenging tissues with interleukin cocktails overexpressed in AD epidermis or by silencing expression of pivotal genes encoding epidermal barrier proteins. Tissue equivalents cocultured with lymphocytes or containing AD patient cells are also described. Furthermore, each model is placed in its study context with a brief summary of the main results obtained. In conclusion, the described in vitro models are useful tools to better understand AD pathogenesis, but also to screen new compounds in the field of AD, which probably will open the way to new preventive or therapeutic strategies. Frontiers Media S.A. 2017-07-24 /pmc/articles/PMC5523664/ /pubmed/28791291 http://dx.doi.org/10.3389/fmed.2017.00119 Text en Copyright © 2017 De Vuyst, Salmon, Evrard, Lambert de Rouvroit and Poumay. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
De Vuyst, Evelyne
Salmon, Michel
Evrard, Céline
Lambert de Rouvroit, Catherine
Poumay, Yves
Atopic Dermatitis Studies through In Vitro Models
title Atopic Dermatitis Studies through In Vitro Models
title_full Atopic Dermatitis Studies through In Vitro Models
title_fullStr Atopic Dermatitis Studies through In Vitro Models
title_full_unstemmed Atopic Dermatitis Studies through In Vitro Models
title_short Atopic Dermatitis Studies through In Vitro Models
title_sort atopic dermatitis studies through in vitro models
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523664/
https://www.ncbi.nlm.nih.gov/pubmed/28791291
http://dx.doi.org/10.3389/fmed.2017.00119
work_keys_str_mv AT devuystevelyne atopicdermatitisstudiesthroughinvitromodels
AT salmonmichel atopicdermatitisstudiesthroughinvitromodels
AT evrardceline atopicdermatitisstudiesthroughinvitromodels
AT lambertderouvroitcatherine atopicdermatitisstudiesthroughinvitromodels
AT poumayyves atopicdermatitisstudiesthroughinvitromodels